Search

Search Constraints

You searched for: Author/Creator Kim, Tae Y.

Search Results

2. Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial. Issue 2 (17th October 2016)